Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 6/2010

01.12.2010 | Laboratory Investigation

A New Soluble Gelatin Sponge for Transcatheter Hepatic Arterial Embolization

verfasst von: Isao Takasaka, Nobuyuki Kawai, Morio Sato, Shinya Sahara, Hiroyuki Minamiguchi, Motoki Nakai, Akira Ikoma, Kouhei Nakata, Tetsuo Sonomura

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

To prepare a soluble gelatin sponge (GS) and to explore the GS particles (GSPs) that inhibit development of collateral pathways when transcatheter hepatic arterial embolization is performed. The approval of the Institutional Committee on Research Animal Care of our institution was obtained. By means of 50 and 100 kDa of regenerative medicine–gelatin (RM-G), RM-G sponges were prepared by freeze-drying and heating to temperatures of 110–150°C for cross-linkage. The soluble times of RM-GSPs were measured in vitro. Eight swine for transcatheter hepatic arterial embolization were assigned into two groups: six received 135°C/50RM-GSPs, 125°C/100RM-GSPs, and 138°C/50RM-GSPs, with soluble time of 48 h or more in vitro; two swine received Gelpart GSPs (G-GSPs) with insoluble time of 14 days as a control. Transarterial chemoembolization was performed on two branches of the hepatic artery per swine. RM-GSPs heated at temperatures of 110–138°C were soluble. Mean soluble times of the RM-GSPs increased with higher temperature. Hepatic branches embolized with G-GSP remained occluded after 6 days, and development of collateral pathways was observed after 3 days. Hepatic branches embolized with 135°C/50RM-GSP and 125°C/100RM-GSP remained occluded for 4 h, and recanalization was observed after 1 day. Hepatic branches embolized with 138°C/50RM-GS remained occluded for 1 day, and recanalization was observed after 2 days with no development of collateral pathways. In RM-GSs with various soluble times that were prepared by modulating the heating temperature, 138°C/50RM-GSP was the soluble GSP with the longest occlusion time without inducing development of collateral pathways.
Literatur
1.
Zurück zum Zitat Doyon D, Mouzon A, Jourde AM et al (1974) L’embolisation arterielle hepatique dans les tumoeurs malignes du foie. Ann Radiol 17:593–603PubMed Doyon D, Mouzon A, Jourde AM et al (1974) L’embolisation arterielle hepatique dans les tumoeurs malignes du foie. Ann Radiol 17:593–603PubMed
2.
Zurück zum Zitat Goldstein HM, Wallace S, Anderson JH et al (1976) Transcatheter occlusion of abdominal tumors. Radiology 120:539–545PubMed Goldstein HM, Wallace S, Anderson JH et al (1976) Transcatheter occlusion of abdominal tumors. Radiology 120:539–545PubMed
3.
Zurück zum Zitat Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401PubMed Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401PubMed
4.
Zurück zum Zitat Katsumori T, Kasahara T (2006) The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 29:1077–1083CrossRefPubMed Katsumori T, Kasahara T (2006) The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 29:1077–1083CrossRefPubMed
5.
Zurück zum Zitat Kim HC, Chung JW, Hong S et al (2007) Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transcatheter chemoembolization and factors affecting patient prognosis. J Vasc Interv Radiol 16:611–620CrossRef Kim HC, Chung JW, Hong S et al (2007) Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transcatheter chemoembolization and factors affecting patient prognosis. J Vasc Interv Radiol 16:611–620CrossRef
6.
Zurück zum Zitat Nakai M, Sato M, Kawai N et al (2001) Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 219:147–152 Nakai M, Sato M, Kawai N et al (2001) Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 219:147–152
7.
Zurück zum Zitat Tanabe N, Iwasaki T, Chida N et al (1998) Hepatocellular carcinoma supplied by inferior phrenic arteries. Acta Radiol 39:443–447PubMed Tanabe N, Iwasaki T, Chida N et al (1998) Hepatocellular carcinoma supplied by inferior phrenic arteries. Acta Radiol 39:443–447PubMed
8.
Zurück zum Zitat Kim HC, Chung W, Lee W et al (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. RadioGraphics 25:25–39CrossRef Kim HC, Chung W, Lee W et al (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. RadioGraphics 25:25–39CrossRef
9.
Zurück zum Zitat Charnsangavei C, Chuang VP, Wallace S et al (1982) Angiographic classification of hepatic arterial collaterals. Radiology 144:485–494 Charnsangavei C, Chuang VP, Wallace S et al (1982) Angiographic classification of hepatic arterial collaterals. Radiology 144:485–494
10.
Zurück zum Zitat Soo CS, Chuang VP, Wallace S et al (1983) Treatment of hepatic neoplasm through extrahepatic collaterals. Radiology 147:45–49PubMed Soo CS, Chuang VP, Wallace S et al (1983) Treatment of hepatic neoplasm through extrahepatic collaterals. Radiology 147:45–49PubMed
11.
Zurück zum Zitat Chung JW, Kim HC, Yoon JH et al (2006) Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Rasiol 7:257–266CrossRef Chung JW, Kim HC, Yoon JH et al (2006) Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Rasiol 7:257–266CrossRef
12.
Zurück zum Zitat Sato M, Yamada R (1983) Experimental and clinical studies on the hepatic artery embolization for treatment of hepatoma. Nippon Acta Radiologica 43:977–1005 Sato M, Yamada R (1983) Experimental and clinical studies on the hepatic artery embolization for treatment of hepatoma. Nippon Acta Radiologica 43:977–1005
13.
Zurück zum Zitat Kanayama Y, Aoki C, Sakai Y (2007) Development of low endotoxin gelatin for regenerative medicine. Biol Pharm Bull 30:237–241CrossRefPubMed Kanayama Y, Aoki C, Sakai Y (2007) Development of low endotoxin gelatin for regenerative medicine. Biol Pharm Bull 30:237–241CrossRefPubMed
14.
Zurück zum Zitat Tanaka K, Sato M, Terada M et al (1988) Echogenic spots early after hepatic arterial embolization. Jpn J Med Ultrasonics 15:397–403 Tanaka K, Sato M, Terada M et al (1988) Echogenic spots early after hepatic arterial embolization. Jpn J Med Ultrasonics 15:397–403
15.
Zurück zum Zitat Segall H (1923) An experimental anatomical investigation of blood and bile channels of the liver. Surg Gynecol Obstet 37:152–178 Segall H (1923) An experimental anatomical investigation of blood and bile channels of the liver. Surg Gynecol Obstet 37:152–178
16.
Zurück zum Zitat Healey JE Jr, Schroy PC, Sorensen RJ (1953) The intrahepatic distribution of the hepatic artery in man. J Int Coll Surg 20:133–148PubMed Healey JE Jr, Schroy PC, Sorensen RJ (1953) The intrahepatic distribution of the hepatic artery in man. J Int Coll Surg 20:133–148PubMed
17.
Zurück zum Zitat Hayashi K, Ina H, Tezuka M et al (2007) Local therapeutic results of computed tomography–guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol 30:1144–1155CrossRefPubMed Hayashi K, Ina H, Tezuka M et al (2007) Local therapeutic results of computed tomography–guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol 30:1144–1155CrossRefPubMed
Metadaten
Titel
A New Soluble Gelatin Sponge for Transcatheter Hepatic Arterial Embolization
verfasst von
Isao Takasaka
Nobuyuki Kawai
Morio Sato
Shinya Sahara
Hiroyuki Minamiguchi
Motoki Nakai
Akira Ikoma
Kouhei Nakata
Tetsuo Sonomura
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 6/2010
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-9866-2

Weitere Artikel der Ausgabe 6/2010

CardioVascular and Interventional Radiology 6/2010 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.